Eton Pharmaceuticals Profit Margin

The latest profit margin for ETON is -1.7% as of March 2026. That compares with -9.49% in the prior-year period — up 82.1% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Eton Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, ETON's profit margin moved from -9.49% to -1.7% — a 82.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eton Pharmaceuticals's valuation or profitability profile.

Against Healthcare companies, ETON currently prints -1.7% for profit margin, while the sector average sits near 15.58%. That is roughly 110.9% below the sector mean. Large gaps often invite a closer look at Eton Pharmaceuticals's growth, margins, and balance sheet.

Profit Margin shows how effectively Eton Pharmaceuticals converts resources into returns. At -1.7%, ETON may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -9.49% in the prior-year period — up 82.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ETON's profit margin (-1.7%), review year-over-year change from -9.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.